Editorial: Lipid metabolism in metabolic dysfunction- associated steatotic liver disease
Saved in:
| Main Authors: | Sheetalnath Rooge, Nirajan Shrestha |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-03-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1584932/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hormone correction of dysfunctional metabolic gene expression in stem cell-derived liver tissue
by: Alvile Kasarinaite, et al.
Published: (2025-03-01) -
Statin Use in Metabolic Dysfunction-Associated Steatotic Liver Disease and Effects on Vibration-Controlled Transient Elastography-Derived Scores—A Population-Based Inverse Probability Treatment Weighting Analysis
by: Natchaya Polpichai, et al.
Published: (2024-12-01) -
Effect of Pemafibrate, a Selective Peroxisome Proliferator-activated Receptor ? Modulator (SPPARM?), on the Lipid Profile, Liver Function, and Liver Fibrosis among Patients with Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
by: Mona Hassan, et al.
Published: (2025-06-01) -
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): the interplay of gut microbiome, insulin resistance, and diabetes
by: Ankita Dua, et al.
Published: (2025-08-01) -
The emerging role of E3 ubiquitin ligases and deubiquitinases in metabolic dysfunction-associated steatotic liver disease
by: Yu Zhang, et al.
Published: (2025-03-01)